A critical advance in cancer research is emerging with the use of nanobodies to restore damaged p53. This essential tumor inhibitor protein is frequently lost in many kinds of tumors, leading uncontrolled body growth. https://dftsocial.com/story23096131/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-approach-for-cancer-management